Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Thrombosis and antiphospholipid antibody syndrome during acute Q fever

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Contributors:
      Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE); Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48; Institut des sciences biologiques - CNRS Biologie (INSB-CNRS)-Institut des sciences biologiques - CNRS Biologie (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS); Vascular research center of Marseille (VRCM); Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM); Centre Hospitalier Universitaire CHU Grenoble (CHUGA); Hôpital d'Instruction des Armées Laveran; Service de Santé des Armées; Centre hospitalier de Valence; Centre Hospitalier Régional Universitaire de Tours (CHRU Tours); Centre Hospitalier Universitaire de Nice (CHU Nice); Centre hospitalier universitaire de Poitiers = Poitiers University Hospital (CHU de Poitiers La Milétrie ); Pharmacologie des anti-infectieux (PHAR Poitiers ); Université de Poitiers = University of Poitiers (UP)-Institut National de la Santé et de la Recherche Médicale (INSERM); Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier); Centre Hospitalier Andrée Rosemon Cayenne, Guyane Française; Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U912 INSERM - Aix Marseille Univ - IRD); Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM); ORS PACA; Laboratoire d'hématologie biologique Hôpital de la Timone - Hôpital Nord - APHM; Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Hôpital de la Timone CHU - APHM (TIMONE)
    • Publication Information:
      CCSD
      Lippincott, Williams & Wilkins
    • Publication Date:
      2017
    • Collection:
      Université de Poitiers: Publications de nos chercheurs.ses (HAL)
    • Abstract:
      International audience ; Q fever is a neglected and potentially fatal disease. During acute Q fever, antiphospholipid antibodies are very prevalent and have been associated with fever, thrombocytopenia, acquired heart valve disease, and progression to chronic endocarditis. However, thrombosis, the main clinical criterion of the 2006 updated classification of the antiphospholipid syndrome, has not been assessed in this context. To test whether thrombosis is associated with antiphospholipid antibodies and whether the criteria for antiphospholipid syndrome can be met in patients with acute Q fever, we conducted a cross-sectional study at the French National Referral Center for Q fever.Patients included were diagnosed with acute Q fever in our Center between January 2007 and December 2015. Each patient's history and clinical characteristics were recorded with a standardized questionnaire. Predictive factors associated with thrombosis were assessed using a rare events logistic regression model. IgG anticardiolipin antibodies (IgG aCL) assessed by an enzyme-linked immunosorbent assay were tested on the Q fever diagnostic serum. A dose-dependent relationship between IgG aCL levels and thrombosis was tested using a receiver operating characteristic (ROC) analysis.Of the 664 patients identified for inclusion in the study, 313 (47.1%) had positive IgG aCL and 13 (1.9%) were diagnosed with thrombosis. Three patients fulfilled the antiphospholipid syndrome criteria. After multiple adjustments, only positive IgG aCL (relative risk, 14.46 [1.85-113.14], P = .011) were independently associated with thrombosis. ROC analysis identified a dose-dependent relationship between IgG aCL levels and occurrence of thrombosis (area under curve, 0.83, 95%CI [0.73-0.93], P < .001).During acute Q fever, antiphospholipid antibodies are associated with thrombosis, thrombocytopenia, and acquired valvular heart disease. Antiphospholipid antibodies should be systematically assessed in acute Q fever patients. Hydroxychloroquine, which has been ...
    • Relation:
      info:eu-repo/semantics/altIdentifier/pmid/28723794; PUBMED: 28723794; PUBMEDCENTRAL: PMC5521934
    • Accession Number:
      10.1097/MD.0000000000007578
    • Online Access:
      https://hal.science/hal-01758322
      https://hal.science/hal-01758322v1/document
      https://hal.science/hal-01758322v1/file/Million%20Medicine.pdf
      https://doi.org/10.1097/MD.0000000000007578
    • Rights:
      info:eu-repo/semantics/OpenAccess
    • Accession Number:
      edsbas.2D55409